{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:31:08Z","timestamp":1793327468553,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002767","name":"Hunan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2025RC3195"],"award-info":[{"award-number":["2025RC3195"]}],"id":[{"id":"10.13039\/501100002767","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/04qgr7x96","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271054"],"award-info":[{"award-number":["82271054"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82530034"],"award-info":[{"award-number":["82530034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82401321"],"award-info":[{"award-number":["82401321"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024JJ6402"],"award-info":[{"award-number":["2024JJ6402"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M741608"],"award-info":[{"award-number":["2023M741608"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/0426zh255","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023J01012"],"award-info":[{"award-number":["2023J01012"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/04aqat463","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009020","name":"University of South China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009020","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.biomaterials.2026.124622","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:56:27Z","timestamp":1789494987000},"page":"124622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PA","title":["Targeted degradation of VEGFR2 via PROTAC encapsulated by cRGD-liposome reverses pathological corneal neovascularization"],"prefix":"10.1016","volume":"338","author":[{"given":"Ke","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaoyue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panqin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5226-3476","authenticated-orcid":false,"given":"Yi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biomaterials.2026.124622_bib1","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1186\/s12951-025-03589-3","article-title":"Recent advances in engineered exosome-based therapies for ocular vascular disease","volume":"23","author":"Guan","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124622_bib2","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/ICO.0b013e318201405a","article-title":"Treatments for corneal neovascularization: a review","volume":"30","author":"Gupta","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.biomaterials.2026.124622_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108457","article-title":"Corneal angiogenic privilege and its failure","volume":"204","author":"Di Zazzo","year":"2021","journal-title":"Exp. Eye Res."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124622_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10456-023-09876-7","article-title":"Pathological angiogenesis: mechanisms and therapeutic strategies","volume":"26","author":"Dudley","year":"2023","journal-title":"Angiogenesis"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124622_bib5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: an anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.biomaterials.2026.124622_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124018","article-title":"Drug-like properties of tyrosine kinase inhibitors in ophthalmology: formulation and topical availability","volume":"655","author":"Jansook","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124622_bib7","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1080\/17425247.2025.2516668","article-title":"Tyrosine kinase inhibitors and their promising role in treating diabetic retinopathy and other retinal vascular diseases: overview of their routes of administration, pharmacokinetics, formulations, and drug delivery applications","volume":"22","author":"Kadavil","year":"2025","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biomaterials.2026.124622_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115535","article-title":"Research progress of VEGFR small molecule inhibitors in ocular neovascular diseases","volume":"257","author":"Jiang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124622_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1021\/cb9002656","article-title":"Biochemical mechanisms of resistance to small-molecule protein kinase inhibitors","volume":"5","author":"Krishnamurty","year":"2010","journal-title":"ACS Chem. Biol."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124622_bib10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF03256446","article-title":"Anticipating clinical resistance to target-directed agents : the BCR-ABL paradigm","volume":"10","author":"Azam","year":"2006","journal-title":"Mol. Diagn. Ther."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124622_bib11","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1039\/D2CS00193D","article-title":"PROTACs: past, present and future","volume":"51","author":"Li","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124622_bib12","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nchembio.1858","article-title":"Catalytic in vivo protein knockdown by small-molecule PROTACs","volume":"11","author":"Bondeson","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"6776","key":"10.1016\/j.biomaterials.2026.124622_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/science.adx5094","article-title":"Targeted protein degradation in the transmembrane and extracellular space","volume":"390","author":"Zhu","year":"2025","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124622_bib14","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.chembiol.2022.08.004","article-title":"Target protein localization and its impact on PROTAC-mediated degradation","volume":"29","author":"Simpson","year":"2022","journal-title":"Cell Chem. Biol."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124622_bib15","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1158\/1535-7163.MCT-05-0410","article-title":"Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor","volume":"5","author":"Albert","year":"2006","journal-title":"Mol. Cancer Therapeut."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124622_bib16","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1080\/07391102.2021.1872417","article-title":"Exploration of structural requirements for the inhibition of VEGFR-2 tyrosine kinase: binding site analysis of type II, 'DFG-out' inhibitors","volume":"40","author":"Modi","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124622_bib17","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1021\/jm061280h","article-title":"Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitor","volume":"50","author":"Dai","year":"2007","journal-title":"J. Med. Chem."},{"issue":"19","key":"10.1016\/j.biomaterials.2026.124622_bib18","doi-asserted-by":"crossref","first-page":"8216","DOI":"10.1039\/D2CS00387B","article-title":"Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders","volume":"51","author":"Diehl","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"16","key":"10.1016\/j.biomaterials.2026.124622_bib19","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M111.219923","article-title":"mTOR complex 2 targets Akt for proteasomal degradation via phosphorylation at the hydrophobic motif","volume":"286","author":"Wu","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biomaterials.2026.124622_bib20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnmol.2011.00051","article-title":"PI3K\/AKT\/mTOR pathway in angiogenesis","volume":"4","author":"Karar","year":"2011","journal-title":"Front. Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124622_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17040501","article-title":"PROTAC delivery strategies for overcoming physicochemical properties and physiological barriers in targeted protein degradation","volume":"17","author":"Syahputra","year":"2025","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124622_bib22","doi-asserted-by":"crossref","first-page":"9584","DOI":"10.1021\/acs.jmedchem.5c00358","article-title":"In vitro ADME profiling of PROTACs: successes, challenges, and lessons learned from analysis of clinical PROTACs from a diverse physicochemical space","volume":"68","author":"Srivastava","year":"2025","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124622_bib23","first-page":"401","article-title":"Liposomal drug delivery: a versatile platform for challenging clinical applications","volume":"17","author":"Madni","year":"2014","journal-title":"J. Pharm. Pharmaceut. Sci."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124622_bib24","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1002\/jps.21358","article-title":"Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development","volume":"97","author":"Drummond","year":"2008","journal-title":"J. Pharmaceut. Sci."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124622_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/1061186X.2018.1473409","article-title":"cRGD functionalised nanocarriers for targeted delivery of bioactives","volume":"27","author":"Gajbhiye","year":"2019","journal-title":"J. Drug Target."},{"key":"10.1016\/j.biomaterials.2026.124622_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112654","article-title":"Discovery of novel anti-angiogenesis agents. Part 11: development of PROTACs based on active molecules with potency of promoting vascular normalization","volume":"205","author":"Shan","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biomaterials.2026.124622_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.672267","article-title":"From conception to development: investigating PROTACs features for improved cell permeability and successful protein degradation","volume":"9","author":"Cecchini","year":"2021","journal-title":"Front. Chem."},{"issue":"86","key":"10.1016\/j.biomaterials.2026.124622_bib28","article-title":"An alkali-burn injury model of corneal neovascularization in the mouse","author":"Anderson","year":"2014","journal-title":"JoVE J."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124622_bib29","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archophthalmol.2009.18","article-title":"Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study","volume":"127","author":"Dastjerdi","year":"2009","journal-title":"Arch. Ophthalmol."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124622_bib30","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1167\/iovs.11-7871","article-title":"Corneal penetration of topical and subconjunctival bevacizumab","volume":"52","author":"Dastjerdi","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"23","key":"10.1016\/j.biomaterials.2026.124622_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500366","article-title":"Recent progress on topical drug therapy for corneal neovascularization","volume":"20","author":"Huang","year":"2025","journal-title":"ChemMedChem"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124622_bib32","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/ajd.12292","article-title":"Ocular side-effects of topical corticosteroids: what a dermatologist needs to know","volume":"56","author":"Daniel","year":"2015","journal-title":"Australas. J. Dermatol."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124622_bib33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jaad.2010.01.035","article-title":"Topical corticosteroids in atopic dermatitis and the risk of glaucoma and cataracts","volume":"64","author":"Haeck","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124622_bib34","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1021\/acs.bioconjchem.5c00305","article-title":"Nanoenabled strategies enhancing PROTACs for cancer therapy","volume":"36","author":"Li","year":"2025","journal-title":"Bioconjug. Chem."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124622_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17081037","article-title":"Recent advances in nanomedicine: Cutting-Edge research on Nano-PROTAC delivery systems for cancer therapy","volume":"17","author":"Wu","year":"2025","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124622_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103387","article-title":"Drug delivery challenges and formulation aspects of proteolysis targeting chimera (PROTACs)","volume":"28","author":"Saraswat","year":"2023","journal-title":"Drug Discov. Today"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124622_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202421713","article-title":"In vivo self-assembly of PROTACs by bioorthogonal chemistry for precision cancer therapy","volume":"64","author":"Xie","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124622_bib38","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1166\/jnn.2014.9082","article-title":"Endosomal escape: a bottleneck in intracellular delivery","volume":"14","author":"Shete","year":"2014","journal-title":"J. Nanosci. Nanotechnol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124622_bib39","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1038\/s41467-024-50235-x","article-title":"Lipid-mediated intracellular delivery of recombinant bioPROTACs for the rapid degradation of undruggable proteins","volume":"15","author":"Chan","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124622_bib40","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1021\/mp100315q","article-title":"Targeted delivery of antisense inhibitor of miRNA for antiangiogenesis therapy using cRGD-functionalized nanoparticles","volume":"8","author":"Liu","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2026.124622_bib41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000320006","article-title":"Mechanisms of ocular angiogenesis and its molecular mediators","volume":"46","author":"Siemerink","year":"2010","journal-title":"Dev. Ophthalmol."},{"issue":"17","key":"10.1016\/j.biomaterials.2026.124622_bib42","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1158\/0008-5472.CAN-15-3107","article-title":"Rebound effects caused by withdrawal of MET kinase inhibitor are quenched by a MET therapeutic antibody","volume":"76","author":"Pupo","year":"2016","journal-title":"Cancer Res."},{"issue":"24","key":"10.1016\/j.biomaterials.2026.124622_bib43","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1038\/s41388-021-01841-2","article-title":"Receptor tyrosine kinases and cancer: oncogenic mechanisms and therapeutic approaches","volume":"40","author":"Saraon","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.biomaterials.2026.124622_bib44","doi-asserted-by":"crossref","DOI":"10.1039\/D5MD00095E","article-title":"Razing the scaffolding: the elimination of non-catalytic functions of kinases through targeted protein degradation","author":"Pogash","year":"2025","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.biomaterials.2026.124622_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.851065","article-title":"FAK PROTAC inhibits ovarian tumor growth and metastasis by disrupting kinase dependent and independent pathways","volume":"12","author":"Huo","year":"2022","journal-title":"Front. Oncol."},{"issue":"49","key":"10.1016\/j.biomaterials.2026.124622_bib46","doi-asserted-by":"crossref","DOI":"10.1021\/jacs.8b08008","article-title":"Addressing kinase-independent functions of fak via PROTAC-Mediated degradation","volume":"140","author":"Cromm","year":"2018","journal-title":"J. Am. Chem. Soc."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124622_bib47","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124622_bib48","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.biomaterials.2026.124622_bib49","series-title":"The Pymol Molecular Graphics System","author":"Schr\u00f6dinger","year":"2024"},{"issue":"16","key":"10.1016\/j.biomaterials.2026.124622_bib50","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124622_bib51","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1021\/acs.molpharmaceut.5c00079","article-title":"Topical administration of mucoadhesive Liposomes-Epoetin-\u03b2 for targeting the ocular posterior segment","volume":"22","author":"Pakian","year":"2025","journal-title":"Mol. Pharm."},{"issue":"28","key":"10.1016\/j.biomaterials.2026.124622_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj0006","article-title":"Dynamically covalent lipid nanoparticles mediate CRISPR-Cas9 genome editing against choroidal neovascularization in mice","volume":"11","author":"Cao","year":"2025","journal-title":"Sci. Adv."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226006460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226006460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:38:11Z","timestamp":1793324291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226006460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":52,"alternative-id":["S0142961226006460"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124622","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted degradation of VEGFR2 via PROTAC encapsulated by cRGD-liposome reverses pathological corneal neovascularization","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124622","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124622"}}